{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T17:15:18Z","timestamp":1783358118171,"version":"3.54.6"},"reference-count":37,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T00:00:00Z","timestamp":1775520000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Medicine"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.clinme.2026.100583","type":"journal-article","created":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T15:52:12Z","timestamp":1777045932000},"page":"100583","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Management of hypertension in chronic kidney disease"],"prefix":"10.1016","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1930-8190","authenticated-orcid":false,"given":"Tim","family":"Doulton","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2568-9871","authenticated-orcid":false,"given":"Pauline A.","family":"Swift","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0010-3416","authenticated-orcid":false,"given":"Swapnil","family":"Hiremath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.clinme.2026.100583_bib1","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1111\/jch.14324","article-title":"Blood pressure measurement: should technique define targets?","volume":"23","author":"Hiremath","year":"2021","journal-title":"J Clin Hypertens"},{"issue":"5","key":"10.1016\/j.clinme.2026.100583_bib2","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1161\/HYPERTENSIONAHA.117.10479","article-title":"Blood pressure measurement in SPRINT (Systolic Blood Pressure Intervention Trial)","volume":"71","author":"Johnson","year":"2018","journal-title":"Hypertension"},{"issue":"3","key":"10.1016\/j.clinme.2026.100583_bib3","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1681\/ASN.2015030243","article-title":"Masked uncontrolled hypertension in CKD","volume":"27","author":"Agarwal","year":"2016","journal-title":"J Am Soc Nephrol"},{"issue":"9","key":"10.1016\/j.clinme.2026.100583_bib4","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002389","article-title":"Self-monitoring of blood pressure in hypertension: a systematic review and individual patient data meta-analysis","volume":"14","author":"Tucker","year":"2017","journal-title":"PLoS Med"},{"issue":"10507","key":"10.1016\/j.clinme.2026.100583_bib5","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/S0140-6736(25)01391-1","article-title":"Benefit-harm trade-offs of intensive blood pressure control versus standard blood pressure control on cardiovascular and renal outcomes: an individual participant data analysis of randomised controlled trials","volume":"406","author":"Guo","year":"2025","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.clinme.2026.100583_bib6","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1053\/j.ajkd.2024.08.010","article-title":"Intensive home blood pressure lowering in patients with advanced CKD","volume":"85","author":"Ku","year":"2025","journal-title":"Am J Kidney Dis"},{"issue":"3s","key":"10.1016\/j.clinme.2026.100583_bib7","first-page":"S1","article-title":"KDIGO 2021 clinical practice guideline for the management of blood pressure in chronic kidney disease","volume":"99","author":"Kidney Disease: Improving Global Outcomes (KDIGO) Blood Pressure Work Group","year":"2021","journal-title":"Kidney Int"},{"key":"10.1016\/j.clinme.2026.100583_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejim.2024.05.033","article-title":"2024 European Society of Hypertension clinical practice guidelines for the management of arterial hypertension","volume":"126","author":"Kreutz","year":"2024","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.clinme.2026.100583_bib9","unstructured":"NICE. Hypertension in adults: diagnosis and management (NG136);\u00a02019\u00a0Updated 21st November 2023. \u3008https:\/\/www.nice.org.uk\/guidance\/NG136\u3009\u00a0Accessed 21st November 2025."},{"key":"10.1016\/j.clinme.2026.100583_bib10","unstructured":"UKKA. UK Kidney Association updated commentary on NICE guideline (NG136) hypertension in adults: diagnosis and management including proposals for blood pressure management in patients with chronic kidney disease, with a brief commentary on KDIGO clinical practice guideline for the management of blood pressure in chronic kidney disease 2021; 2021\u00a0Updated December 2022. \u3008https:\/\/www.ukkidney.org\/sites\/default\/files\/FINAL%20UKKA%20NICE-KDIGO%20commentary%20December%202022.pdf\u3009\u00a0Accessed 17th January 2026."},{"issue":"38","key":"10.1016\/j.clinme.2026.100583_bib11","doi-asserted-by":"crossref","first-page":"3912","DOI":"10.1093\/eurheartj\/ehae178","article-title":"2024 ESC guidelines for the management of elevated blood pressure and hypertension","volume":"45","author":"McEvoy","year":"2024","journal-title":"Eur Heart J"},{"issue":"10","key":"10.1016\/j.clinme.2026.100583_bib12","first-page":"e212","volume":"82","author":"Jones","year":"2025","journal-title":"Hypertension"},{"issue":"20","key":"10.1016\/j.clinme.2026.100583_bib13","doi-asserted-by":"crossref","first-page":"E549","DOI":"10.1503\/cmaj.241770","article-title":"Hypertension Canada guideline for the diagnosis and treatment of hypertension in adults in primary care","volume":"197","author":"Goupil","year":"2025","journal-title":"CMAJ"},{"issue":"12","key":"10.1016\/j.clinme.2026.100583_bib14","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1681\/ASN.2013030285","article-title":"A randomized trial of dietary sodium restriction in CKD","volume":"24","author":"McMahon","year":"2013","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"10.1016\/j.clinme.2026.100583_bib15","article-title":"Altered dietary salt intake for people with chronic kidney disease","volume":"6","author":"McMahon","year":"2021","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"10.1016\/j.clinme.2026.100583_bib16","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/ki.2012.74","article-title":"Moderation of dietary sodium potentiates the renal and cardiovascular protective effects of angiotensin receptor blockers","volume":"82","author":"Lambers Heerspink","year":"2012","journal-title":"Kidney Int"},{"issue":"5","key":"10.1016\/j.clinme.2026.100583_bib17","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1681\/ASN.2007060693","article-title":"Effects of dietary sodium and hydrochlorothiazide on the antiproteinuric efficacy of losartan","volume":"19","author":"Vogt","year":"2008","journal-title":"J Am Soc Nephrol"},{"issue":"4s","key":"10.1016\/j.clinme.2026.100583_bib18","first-page":"S117","article-title":"KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease","volume":"105","author":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group","year":"2024","journal-title":"Kidney Int"},{"issue":"1","key":"10.1016\/j.clinme.2026.100583_bib19","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1056\/NEJM200101043440101","article-title":"Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group","volume":"344","author":"Sacks","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinme.2026.100583_bib20","article-title":"Impact of kidney function on effects of the dietary approaches to stop hypertension (DASH) diet","volume":"3","author":"Tyson","year":"2014","journal-title":"J Hypertens"},{"issue":"4","key":"10.1016\/j.clinme.2026.100583_bib21","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1093\/ckj\/sfw046","article-title":"Short-term effects of the DASH diet in adults with moderate chronic kidney disease: a pilot feeding study","volume":"9","author":"Tyson","year":"2016","journal-title":"Clin Kidney J"},{"issue":"2","key":"10.1016\/j.clinme.2026.100583_bib22","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0211032","article-title":"The effect of exercise on blood pressure in chronic kidney disease: a systematic review and meta-analysis of randomized controlled trials","volume":"14","author":"Thompson","year":"2019","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.clinme.2026.100583_bib23","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1186\/s12882-019-1586-5","article-title":"Exercise therapy improves eGFR, and reduces blood pressure and BMI in non-dialysis CKD patients: evidence from a meta-analysis","volume":"20","author":"Zhang","year":"2019","journal-title":"BMC Nephrol"},{"issue":"5","key":"10.1016\/j.clinme.2026.100583_bib24","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.eprac.2024.03.001","article-title":"Effect of sodium-glucose cotransporter 2 inhibitors on the 24-hour ambulatory blood pressure in patients with type 2 diabetes mellitus and hypertension: an updated meta-analysis","volume":"30","author":"Iqbal","year":"2024","journal-title":"Endocr Pract"},{"issue":"23","key":"10.1016\/j.clinme.2026.100583_bib25","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1056\/NEJMoa2025845","article-title":"Effect of finerenone on chronic kidney disease outcomes in type 2 diabetes","volume":"383","author":"Bakris","year":"2020","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.clinme.2026.100583_bib26","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1056\/NEJMoa2410659","article-title":"Finerenone with empagliflozin in chronic kidney disease and type 2 diabetes","volume":"393","author":"Agarwal","year":"2025","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.clinme.2026.100583_bib27","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1056\/NEJMoa2403347","article-title":"Effects of semaglutide on chronic kidney disease in patients with type 2 diabetes","volume":"391","author":"Perkovic","year":"2024","journal-title":"N Engl J Med"},{"issue":"22","key":"10.1016\/j.clinme.2026.100583_bib28","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1056\/NEJMoa2210639","article-title":"Renin-angiotensin system inhibition in advanced chronic kidney disease","volume":"387","author":"Bhandari","year":"2022","journal-title":"N Engl J Med"},{"issue":"27","key":"10.1016\/j.clinme.2026.100583_bib29","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1056\/NEJMoa2110730","article-title":"Chlorthalidone for hypertension in advanced chronic kidney disease","volume":"385","author":"Agarwal","year":"2021","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.clinme.2026.100583_bib30","doi-asserted-by":"crossref","DOI":"10.1093\/ckj\/sfae083","article-title":"Maintained renin-angiotensin-aldosterone system inhibitor therapy with sodium zirconium cyclosilicate following a hyperkalaemia episode: a multicountry cohort study","volume":"17","author":"Rastogi","year":"2024","journal-title":"Clin Kidney J"},{"issue":"2","key":"10.1016\/j.clinme.2026.100583_bib31","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1093\/ndt\/gfae132","article-title":"Design and baseline characteristics of the Finerenone, in addition to standard of care, on the progression of kidney disease in patients with non-diabetic chronic kidney disease (FIND-CKD) randomized trial","volume":"40","author":"Heerspink","year":"2025","journal-title":"Nephrol Dial Transplant"},{"issue":"14","key":"10.1016\/j.clinme.2026.100583_bib32","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1056\/NEJMoa2507109","article-title":"Efficacy and safety of baxdrostat in uncontrolled and resistant hypertension","volume":"393","author":"Flack","year":"2025","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.clinme.2026.100583_bib33","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1001\/jama.2025.9413","article-title":"Lorundrostat in participants with uncontrolled hypertension and treatment-resistant hypertension: the launch-HTN randomized clinical trial","volume":"334","author":"Saxena","year":"2025","journal-title":"JAMA"},{"key":"10.1016\/j.clinme.2026.100583_bib34","unstructured":"A phase III, randomised, double-blind, placebo-controlled, event-driven study to assess the efficacy, safety and tolerability of baxdrostat in combination with dapagliflozin compared with dapagliflozin alone on renal outcomes and cardiovascular mortality in participants with chronic kidney disease and high blood pressure;\u00a02024. \u3008https:\/\/clinicaltrials.gov\/study\/NCT06742723\u3009."},{"issue":"6","key":"10.1016\/j.clinme.2026.100583_bib35","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1093\/ndt\/gfae263","article-title":"The potential for improving cardio-renal outcomes in chronic kidney disease with the aldosterone synthase inhibitor vicadrostat (BI 690517): a rationale for the EASi-KIDNEY trial","volume":"40","author":"Judge","year":"2025","journal-title":"Nephrol Dial Transplant"},{"issue":"10367","key":"10.1016\/j.clinme.2026.100583_bib36","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1016\/S0140-6736(22)02034-7","article-title":"Dual endothelin antagonist aprocitentan for resistant hypertension (PRECISION): a multicentre, blinded, randomised, parallel-group, phase 3 trial","volume":"400","author":"Schlaich","year":"2022","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.clinme.2026.100583_bib37","doi-asserted-by":"crossref","DOI":"10.1093\/ckj\/sfaf126","article-title":"Renal denervation is effective in reducing blood pressure in patients with CKD","volume":"18","author":"Bosch","year":"2025","journal-title":"Clin Kidney J"}],"container-title":["Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1470211826000321?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1470211826000321?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T16:23:36Z","timestamp":1783355016000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1470211826000321"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":37,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S1470211826000321"],"URL":"https:\/\/doi.org\/10.1016\/j.clinme.2026.100583","relation":{},"ISSN":["1470-2118"],"issn-type":[{"value":"1470-2118","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Management of hypertension in chronic kidney disease","name":"articletitle","label":"Article Title"},{"value":"Clinical Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinme.2026.100583","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2026 Published by Elsevier Ltd on behalf of Royal College of Physicians.","name":"copyright","label":"Copyright"}],"article-number":"100583"}}